Nicotine Mini 2 mg/1 (Nicotine Polacrilex LOZENGE) 2 mg/1

Nicotine Mini 2 mg/1 lozenges help manage nicotine cravings for smoking cessation. These oral lozenges provide a 2 mg dose of nicotine polacrilex to support quitting smoking.

Strength

2 mg/1

Pack Size

3 BOTTLE, PLASTIC in 1 BOTTLE (0363-0262-81) / 27 LOZENGE in 1 BOTTLE, PLASTIC

Manufacturer / TM Owner

Walgreens

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nicotine Mini 2 mg/1 lozenges are designed to aid in smoking cessation by providing a controlled release of nicotine. They are used to help reduce withdrawal symptoms and cravings associated with quitting smoking. Nicotine replacement therapy, such as these lozenges, can be part of a broader strategy to quit smoking.

Side Effects

When used as directed, Nicotine Mini 2 mg/1 lozenges can help alleviate nicotine cravings and withdrawal symptoms. Users may experience a gradual reduction in the urge to smoke, supporting their efforts to quit. Common effects include a tingling or cooling sensation in the mouth.

Precautions & Warnings

Nicotine Mini 2 mg/1 lozenges should be used as directed and stored out of reach of children. Individuals with certain medical conditions, such as heart disease or high blood pressure, should consult a healthcare provider before use. Avoid chewing or swallowing the lozenge whole; allow it to dissolve slowly in the mouth.

Avoid Interactions

Nicotine Mini 2 mg/1 lozenges may interact with certain medications, including those for heart conditions or high blood pressure. It is important to inform a healthcare provider about all medications being taken. Avoid using other nicotine products simultaneously to prevent excessive nicotine intake.

Frequently Asked Questions

Nicotine Mini 2 mg/1 lozenges are used to help manage nicotine cravings and withdrawal symptoms as part of a smoking cessation program.

These lozenges release nicotine slowly in the mouth, helping to reduce cravings and withdrawal symptoms associated with quitting smoking.

It is generally not recommended to use Nicotine Mini 2 mg/1 lozenges with other nicotine products to avoid excessive nicotine intake.

If you experience any adverse effects, discontinue use and consult a healthcare provider for advice.

Store Nicotine Mini 2 mg/1 lozenges at room temperature, away from moisture and heat, and keep them out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.